Providence Capital Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-61
| Closed | -$214 | – | 181 |
|
|
2024
Q3 | $214 | Hold |
61
| – | – | ﹤0.01% | 346 |
|
|
2024
Q2 | $200 | Hold |
61
| – | – | ﹤0.01% | 348 |
|
|
2024
Q1 | $448 | Hold |
61
| – | – | ﹤0.01% | 329 |
|
|
2023
Q4 | $228 | Hold |
61
| – | – | ﹤0.01% | 329 |
|
|
2023
Q3 | $129 | Hold |
61
| – | – | ﹤0.01% | 346 |
|
|
2023
Q2 | $290 | Hold |
61
| – | – | ﹤0.01% | 303 |
|
|
2023
Q1 | $348 | Hold |
61
| – | – | ﹤0.01% | 298 |
|
|
2022
Q4 | $615 | Hold |
61
| – | – | ﹤0.01% | 275 |
|
|
2022
Q3 | $1K | Hold |
61
| – | – | ﹤0.01% | 298 |
|
|
2022
Q2 | $2K | Sell |
61
-17
| -22% | -$557 | ﹤0.01% | 261 |
|
|
2022
Q1 | $3K | Buy |
78
+17
| +28% | +$654 | ﹤0.01% | 304 |
|
|
2021
Q4 | $4K | Hold |
61
| – | – | ﹤0.01% | 277 |
|
|
2021
Q3 | $4K | Hold |
61
| – | – | ﹤0.01% | 252 |
|
|
2021
Q2 | $5K | Hold |
61
| – | – | ﹤0.01% | 252 |
|
|
2021
Q1 | $5K | Sell |
61
-30
| -33% | -$2.46K | ﹤0.01% | 220 |
|
|
2020
Q4 | $8K | Buy |
+91
| New | +$8K | ﹤0.01% | 226 |
|